ikon Prescription Drugs: Top 300

4.70.2291 by gWhiz


May 16, 2017

Tentang Prescription Drugs: Top 300

Indonesia

★★★★★ Segala sesuatu yang Anda perlu tahu tentang atas 300 obat yang paling-resep.

Learning essential information about the top 300 prescription drugs doesn’t have to be tedious. With Prescription Drug Cards: Top 300, you’ll get a comprehensive, easy-to-use study tool that will tell you everything you need to know about these most-prescribed drugs. And as a bonus, you’ll get the top 100 non-prescription drugs, too. This tool is ready to go with quick image and information retrieval—no Internet connection necessary!

Features:

You’ll learn crucial information about the top 300 prescription drugs, including:

✓ Generic and common name

✓ Class

✓ Dosage Forms

✓ Approved Dose and Indications

✓ Off-Label Use

✓ Contraindications

✓ Adverse Reactions

✓ Drug Interactions

✓ Monitoring Parameters

✓ Medication Safety Issues and Black Box Warnings

Learn vital drug information: Download Prescription Drug Cards: Top 300!

Apa yang baru dalam versi terbaru 4.70.2291

Last updated on May 16, 2017

This version includes a few improvements to make your study experience smoother.

Let us know what you think by emailing us at feedback@hltcorp.com or by leaving a 5-star review.

Terjemahan Memuat...

Informasi APL tambahan

Versi Terbaru

Permintaan Prescription Drugs: Top 300 Update 4.70.2291

Diunggah oleh

Marvin Guerrero Fernandez

Perlu Android versi

Android 5.0+

Tampilkan Selengkapnya

Juga tersedia untuk platform lain

Prescription Drugs: Top 300 Tangkapan layar

Komentar Loading...
Bahasa
Bahasa
Cari...
Berlangganan APKPure
Jadilah yang pertama mendapatkan akses ke rilis awal, berita, dan panduan dari game dan aplikasi Android terbaik.
Tidak, terima kasih
Mendaftar
Berlangganan dengan sukses!
Anda sekarang berlangganan APKPure.
Berlangganan APKPure
Jadilah yang pertama mendapatkan akses ke rilis awal, berita, dan panduan dari game dan aplikasi Android terbaik.
Tidak, terima kasih
Mendaftar
Kesuksesan!
Anda sekarang berlangganan buletin kami.